Related Experiment Video

Updated: Jul 9, 2026

Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design

Xiaoyu Xue1, Hongwei Yu, Haitao Yang

  • 1Laboratory of Structural Biology, Life Sciences Building, Tsinghua University, Beijing 100084, China.

Journal of Virology
|December 21, 2007
PubMed

Insights

Coronaviruses pose a significant threat, but targeting their main protease (M(pro)) offers a promising avenue for drug development. This study reveals structural insights and identifies potent inhibitors against M(pro) for broad-spectrum antiviral therapies.

Area of Science:

  • Structural biology
  • Virology
  • Drug discovery

Background:

  • Coronaviruses (CoVs) infect humans and animals, causing diverse diseases.
  • The coronavirus main protease (M(pro)) is crucial for viral replication and a key drug target.

Purpose of the Study:

  • To elucidate the structural flexibility and substrate binding of M(pro) through crystal structure determination.
  • To identify novel inhibitors targeting CoV M(pro) for antiviral drug development.

Main Methods:

  • Determined crystal structures of infectious bronchitis virus (IBV) M(pro) and a SARS-CoV M(pro) mutant (H41A) complexed with a substrate.
  • Cocrystallized IBV M(pro) with a Michael acceptor inhibitor (N3) and optimized it into lead compounds (N27, H16).

Main Results:

  • Identified a monomeric form of IBV M(pro) for the first time.
  • Demonstrated in vitro inactivation of IBV M(pro) by N3 and potent antiviral activity in chicken embryos.
  • Developed N27 and H16 with potent inhibition against SARS-CoV M(pro).

Conclusions:

  • Structural insights into M(pro) aid in designing substrate-based inhibitors.
  • N3 and its derivatives show promise as broad-spectrum antiviral agents against CoVs.
  • Chicken embryo model is effective for evaluating antiviral efficacy.

More Related Videos

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation07:53

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation

Published on: January 9, 2019

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods10:40

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Published on: December 21, 2019

Related Concept Videos

Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Viral Structure00:56

Viral Structure

Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...